Related Experiment Video
Updated: Jun 30, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
Identification of candidate tumor suppressor genes inactivated by promoter methylation in melanoma
Vanessa F Bonazzi1, Darryl Irwin, Nicholas K Hayward
1Oncogenomics Laboratory, Queensland Institute of Medical Research, Herston, QLD 4006, Australia.
Abstract:
Tumor suppressor genes (TSGs) are sometimes inactivated by transcriptional silencing through promoter hypermethylation. To identify novel methylated TSGs in melanoma, we carried out global mRNA expression profiling on a panel of 12 melanoma cell lines treated with a combination of 5-Aza-2-deoxycytidine (5AzadC) and an inhibitor of histone deacetylase, Trichostatin A. Reactivation of gene expression after drug treatment was assessed using Illumina whole-genome microarrays. After qRT-PCR confirmation, we followed up 8 genes (AKAP12, ARHGEF16, ARHGAP27, ENC1, PPP1R3C, PPP1R14C, RARRES1, and TP53INP1) by quantitative DNA methylation analysis using mass spectrometry of base-specific cleaved amplification products in panels of melanoma cell lines and fresh tumors. PPP1R3C, ENC1, RARRES1, and TP53INP1, showed reduced mRNA expression in 35-59% of the melanoma cell lines compared to melanocytes and which was correlated with a high proportion of promoter methylation (>40-60%). The same genes also showed extensive promoter methylation in 6-25% of the tumor samples, thus confirming them as novel candidate TSGs in melanoma.
Insights
Researchers identified novel tumor suppressor genes (TSGs) in melanoma by analyzing gene expression and promoter methylation. Four genes (PPP1R3C, ENC1, RARRES1, TP53INP1) were confirmed as potential TSGs due to hypermethylation and reduced expression in melanoma.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Tumor suppressor genes (TSGs) are crucial for preventing cancer development.
- Transcriptional silencing via promoter hypermethylation is a key mechanism for TSG inactivation in various cancers, including melanoma.
- Identifying novel methylated TSGs in melanoma is essential for understanding disease progression and developing targeted therapies.
Purpose of the Study:
- To identify novel methylated tumor suppressor genes (TSGs) in melanoma.
- To investigate the correlation between promoter hypermethylation and gene expression silencing in melanoma.
- To validate candidate TSGs in melanoma cell lines and tumor samples.
Main Methods:
- Global mRNA expression profiling of 12 melanoma cell lines treated with 5-Aza-2-deoxycytidine (5AzadC) and Trichostatin A.
- Illumina whole-genome microarrays to assess gene expression reactivation.
- Quantitative DNA methylation analysis using mass spectrometry on selected genes in melanoma cell lines and tumors.
Main Results:
- Eight candidate genes (AKAP12, ARHGEF16, ARHGAP27, ENC1, PPP1R3C, PPP1R14C, RARRES1, TP53INP1) were identified for further analysis.
- Four genes (PPP1R3C, ENC1, RARRES1, TP53INP1) exhibited reduced mRNA expression in 35-59% of melanoma cell lines compared to melanocytes.
- These four genes showed a strong correlation between reduced expression and high promoter methylation (>40-60%) in cell lines, and extensive promoter methylation (6-25%) in tumor samples.
Conclusions:
- PPP1R3C, ENC1, RARRES1, and TP53INP1 are identified as novel candidate tumor suppressor genes in melanoma.
- Promoter hypermethylation is a significant mechanism for the inactivation of these TSGs in melanoma.
- These findings provide new targets for understanding melanoma pathogenesis and potential therapeutic strategies.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

